Brii Biosciences Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-375.69	-508.16	-174.83	-484.31	-4,164	-1,190
Depreciation & Amortization	5.16	8.45	15.27	16.63	17.26	14.21
Other Amortization	0.4	0.4	0.4	0.4	-	-
Asset Writedown & Restructuring Costs	90.35	90.35	5.43	-	-	-
Loss (Gain) From Sale of Investments	109.69	109.69	-136.24	-31.69	-44.8	15.02
Stock-Based Compensation	16.05	16.05	64.22	77.93	79.37	29.48
Provision & Write-off of Bad Debts	50.79	50.79	-	-	-	-
Other Operating Activities	-214.82	-90.05	-247.54	1.75	3,566	255.72
Change in Accounts Payable	-17.27	-17.27	-81.46	-58.14	-286.62	477.59
Change in Unearned Revenue	-33.69	-33.69	-6.13	-3.21	-21.94	17.88
Change in Other Net Operating Assets	0.55	0.55	-33.14	-15.65	-25.18	-24.02
Operating Cash Flow	-368.48	-372.89	-594.01	-496.28	-879.46	-403.72
Capital Expenditures	-2.49	-3.23	-	-	-1.03	-
Sale (Purchase) of Intangibles	-125.79	-	-49.61	-139.29	-	-
Investment in Securities	1,179	888.37	-225.92	-1,333	-479.65	-44.61
Other Investing Activities	199.52	10.33	171.17	38.65	4.92	0.96
Investing Cash Flow	1,251	895.47	-104.35	-1,433	-475.76	-43.65
Long-Term Debt Repaid	-	-6.87	-9.5	-8.96	-9.75	-6.79
Net Debt Issued (Repaid)	-6.06	-6.87	-9.5	-8.96	-9.75	-6.79
Issuance of Common Stock	0.24	0.05	0.18	7.45	2,325	0.14
Repurchase of Common Stock	-17.12	-0.22	-1.16	-0.68	-	-
Other Financing Activities	-3.28	-2.37	-0.49	-0.85	-87.81	-4.74
Financing Cash Flow	-26.21	-9.41	-10.98	-3.04	3,230	657
Foreign Exchange Rate Adjustments	-4.8	0.54	8.42	267.97	-54.79	-55.03
Net Cash Flow	851.24	513.72	-700.92	-1,665	1,820	154.61
Free Cash Flow	-370.97	-376.12	-594.01	-496.28	-880.49	-403.72
Free Cash Flow Margin	-1289.25%	-753.20%	-1062.81%	-405.86%	-951.45%	-491.03%
Free Cash Flow Per Share	-0.51	-0.52	-0.82	-0.69	-2.00	-2.11
Cash Interest Paid	3.28	2.37	0.49	0.85	1.18	1.67
Levered Free Cash Flow	-200.53	-254.09	-447.14	-438.46	-603.47	-37.34
Unlevered Free Cash Flow	-198.48	-252.61	-446.83	-437.93	-602.74	-36.3
Change in Working Capital	-50.41	-50.41	-120.73	-76.99	-333.74	471.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.